Evidence map›Paper›PMID 26835508›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)

Insight into Best Variables for COPD Case Identification: A Random Forests Analysis.

Nancy K Leidy, Karen G Malley, Anna W Steenrod, David M Mannino, Barry J Make, Russ P Bowler, Byron M Thomashow, R G Barr, Stephen I Rennard, Julia F Houfek and 6 more

Abstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nancy K LeidyEvidera, Bethesda, Maryland.
Karen G MalleyEvidera, Bethesda, Maryland.
Anna W SteenrodEvidera, Bethesda, Maryland.
David M ManninoUniversity of Kentucky, Lexington, Kentucky.
Barry J MakeNational Jewish Health, Denver, Colorado.
Russ P BowlerNational Jewish Health, Denver, Colorado.
Byron M ThomashowColumbia University, New York, New York.
R G BarrColumbia University, New York, New York.
Stephen I RennardUniversity of Nebraska, Omaha, Nebraska.
Julia F HoufekUniversity of Nebraska, Omaha, Nebraska.
Barbara P YawnOlmsted Medical Center, Rochester, Minnesota.
Meilan K HanUniversity of Michigan, Ann Arbor, Michigan.
Catherine A MeldrumUniversity of Michigan, Ann Arbor, Michigan.
Elizabeth D BacciEvidera, Bethesda, Maryland.
John W WalshCOPD Foundation, Washington, DC.
Fernando MartinezWeill Cornell Medical Center, New York, New York.

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Design and Testing of tools to Identify individuals at high risk for COPD^ 73R01HL114055 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEIDY, NANCY KLINE, MANNINO, DAVID · 2012 to 2014
$2.4M
NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R01 HL114055NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

rationaleThis study is part of a larger, multi-method project to develop a questionnaire for identifying undiagnosed cases of chronic obstructive pulmonary disease (COPD) in primary care settings, with specific interest in the detection of patients with moderate to severe airway obstruction or risk of exacerbation.

objectivesTo examine 3 existing datasets for insight into key features of COPD that could be useful in the identification of undiagnosed COPD.

methodsRandom forests analyses were applied to the following databases: COPD Foundation Peak Flow Study Cohort (N=5761), Burden of Obstructive Lung Disease (BOLD) Kentucky site (N=508), and COPDGene® (N=10,214). Four scenarios were examined to find the best, smallest sets of variables that distinguished cases and controls:(1) moderate to severe COPD (forced expiratory volume in 1 second [FEV

resultsFrom 4 to 8 variables were able to differentiate cases from controls, with sensitivity ≥73 (range: 73-90) and specificity >68 (range: 68-93). Across scenarios, the best models included age, smoking status or history, symptoms (cough, wheeze, phlegm), general or breathing-related activity limitation, episodes of acute bronchitis, and/or missed work days and non-work activities due to breathing or health.

conclusionsResults provide insight into variables that should be considered during the development of candidate items for a new questionnaire to identify undiagnosed cases of clinically significant COPD.

Indexed as

case identificationchronic airways obstructionCOPDdata miningprimary carerandom forestsscreening

Identifiers

PMID26835508
PMCPMC4729451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.